Carnegie Investment Counsel’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,916
| Closed | -$204K | – | 478 |
|
|
2024
Q3 | $204K | Buy |
+2,916
| New | +$204K | 0.01% | 455 |
|
|
2023
Q1 | – | Sell |
-3,715
| Closed | -$236K | – | 521 |
|
|
2022
Q4 | $236K | Hold |
3,715
| – | – | 0.01% | 458 |
|
|
2022
Q3 | $219K | Hold |
3,715
| – | – | 0.01% | 440 |
|
|
2022
Q2 | $215K | Sell |
3,715
-100
| -3% | -$5.79K | 0.01% | 445 |
|
|
2022
Q1 | $237K | Sell |
3,815
-200
| -5% | -$12.4K | 0.01% | 448 |
|
|
2021
Q4 | $286K | Hold |
4,015
| – | – | 0.01% | 427 |
|
|
2021
Q3 | $301K | Hold |
4,015
| – | – | 0.01% | 386 |
|
|
2021
Q2 | $311K | Hold |
4,015
| – | – | 0.01% | 387 |
|
|
2021
Q1 | $296K | Sell |
4,015
-400
| -9% | -$29.5K | 0.01% | 379 |
|
|
2020
Q4 | $310K | Hold |
4,415
| – | – | 0.01% | 357 |
|
|
2020
Q3 | $250K | Hold |
4,415
| – | – | 0.01% | 366 |
|
|
2020
Q2 | $257K | Hold |
4,415
| – | – | 0.01% | 365 |
|
|
2020
Q1 | $205K | Hold |
4,415
| – | – | 0.01% | 375 |
|
|
2019
Q4 | $247K | Sell |
4,415
-400
| -8% | -$22.4K | 0.01% | 383 |
|
|
2019
Q3 | $228K | Hold |
4,815
| – | – | 0.01% | 392 |
|
|
2019
Q2 | $258K | Hold |
4,815
| – | – | 0.02% | 377 |
|
|
2019
Q1 | $266K | Hold |
4,815
| – | – | 0.02% | 361 |
|
|
2018
Q4 | $227K | Sell |
4,815
-515
| -10% | -$24.3K | 0.02% | 337 |
|
|
2018
Q3 | $271K | Buy |
5,330
+515
| +11% | +$26.2K | 0.02% | 299 |
|
|
2018
Q2 | $280K | Hold |
4,815
| – | – | 0.02% | 326 |
|
|
2018
Q1 | $243K | Hold |
4,815
| – | – | 0.02% | 335 |
|
|
2017
Q4 | $245K | Hold |
4,815
| – | – | 0.02% | 346 |
|
|
2017
Q3 | $232K | Hold |
4,815
| – | – | 0.03% | 325 |
|
|
2017
Q2 | $225K | Buy |
4,815
+2
| +0% | +$93 | 0.03% | 324 |
|
|
2017
Q1 | $205K | Buy |
+4,813
| New | +$205K | 0.03% | 327 |
|
|
2016
Q4 | – | Sell |
-6,410
| Closed | -$248K | – | 337 |
|
|
2016
Q3 | $248K | Sell |
6,410
-350
| -5% | -$13.5K | 0.04% | 277 |
|
|
2016
Q2 | $276K | Hold |
6,760
| – | – | 0.04% | 269 |
|
|
2016
Q1 | $259K | Hold |
6,760
| – | – | 0.04% | 264 |
|
|
2015
Q4 | $260K | Sell |
6,760
-97
| -1% | -$3.73K | 0.05% | 253 |
|
|
2015
Q3 | $344K | Buy |
6,857
+1
| +0% | +$50 | 0.06% | 228 |
|
|
2015
Q2 | $400K | Buy |
6,856
+1
| +0% | +$58 | 0.07% | 211 |
|
|
2015
Q1 | $398K | Hold |
6,855
| – | – | 0.07% | 212 |
|
|
2014
Q4 | $360K | Hold |
6,855
| – | – | 0.07% | 211 |
|
|
2014
Q3 | $317K | Buy |
6,855
+505
| +8% | +$23.4K | 0.06% | 226 |
|
|
2014
Q2 | $278K | Sell |
6,350
-450
| -7% | -$19.7K | 0.06% | 195 |
|
|
2014
Q1 | $283K | Sell |
6,800
-50
| -0.7% | -$2.08K | 0.07% | 179 |
|
|
2013
Q4 | $254K | Hold |
6,850
| – | – | 0.07% | 191 |
|
|
2013
Q3 | $240K | Buy |
+6,850
| New | +$240K | 0.07% | 187 |
|